FSAI recalls batch of Dutch cannabis oil
The authority has recalled 10ml bottles of extra strong Euphoria Full spectrum Oil
The bike tour – Mila’s diary by Che Capri
Over 80 riders and volunteers from around the world took part, travelling 420km over 3 days
Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinol
Pain, spasticity, tremor, spasms, poor sleep quality, and bladder and bowel dysfunction, among other symptoms, contribute significantly to the disability and impaired quality of life of many patients with multiple sclerosis (MS). Motor symptoms referable to the basal ganglia, especially paroxysmal dystonia, occur rarely and contribute to the experience of distress. An illustrative case is presented of a 52-year-old woman with MS, paroxysmal dystonia, complex vocal tics, and marijuana dependence.
Cannabis Medicine at home Part 3 Custom Capsules by Nugs & Nurse Tori
The true beauty of Custom Capsules is the individuality and versatility of the preparation.
US growing bumper crop for medical marijuana research
Researchers should be able to obtain material from the new crop in the fall after harvest and analyses are completed
Medical marijuana: medical necessity versus political agenda
Marijuana is classified by the Drug Enforcement Agency (DEA) as an illegal Schedule I drug which has no accepted medical use. However, recent studies have shown that medical marijuana is effective in controlling chronic non-cancer pain, alleviating nausea and vomiting associated with chemotherapy, treating wasting syndrome associated with AIDS, and controlling muscle spasms due to multiple sclerosis.
Patients have a right to all beneficial treatments and to deny them this right violates their basic human rights.
THC Can Prevent Transplanted Organs From Being Rejected
A recent study shows that THC can prevent organ rejection in mice.
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
A great need exists for the development of new medications to treat pain resulting from various disease states and types of injury. Given that the endogenous cannabinoid (that is, endocannabinoid) system modulates neuronal and immune cell function, both of which play key roles in pain, therapeutics targeting this system hold promise as novel analgesics. Here we examine the preclinical and clinical evidence of various endocannabinoid system targets as potential therapeutic strategies for inflammatory and neuropathic pain conditions.
Meet Ken from Happy Daddy Products – by T Curtiss
“We came up with an integrated way to smoke, so that we could get the very best flavor, and…medication.”
Cannabis in palliative care: current challenges and practical recommendations
Pain and symptom control challenges are common in palliative care, and the search for other therapeutic strategies is ongoing. Unfortunately, patients and their caregivers are receiving little information or support from healthcare providers regarding the increasingly popular cannabinoid-based medicines (CBM).
